Clinical Trial Update: Olaparib in PALB2 Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluates olaparib in PALB2-associated advanced/metastatic pancreatic cancer; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Lynparza (olaparib)

Snippet

Sponsor: Azienda Ospedaliero-Universitaria di Modena | Conditions: Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer | Phase 2 | Status: RECRUITING